Chewable Tablets
Composition:
Each tablet contains: Active ingredient: simethicone (activated dimethylpolysiloxane) 40 mg. For a full list of excipients, see 6.1.
Excipients
Saccharin, Alginic acid, Lactose, Sodium bicarbonate, Povidone, Calcium silicate hydrate, Magnesium stearate.
Therapeutic indications
Symptomatic treatment of gastrointestinal flatulence and aerophagia in adults.
Contraindications
Hypersensitivity to the active substance or to any of the excipients. Generally contraindicated during pregnancy (see section 4.6).
Dosage
Adults: 4 tablets per day (2 at the end of each main meal). The tablets must be chewed.
Warnings and precautions
Do not exceed the recommended dose. After a short period of treatment without noticeable results, consult your doctor. The medicine contains lactose and is therefore not suitable for individuals with lactase deficiency, galactosemia, or glucose-galactose malabsorption syndrome.
Interactions
No incompatibilities with other medications are known or reported.
Side effects
No side effects due to MYLICONGAS have been observed.
Pregnancy and breastfeeding
Pregnancy. There are no adequate data on the use of MYLICONGAS in pregnant women, therefore it should not be used during pregnancy unless clearly necessary and after a risk/benefit assessment by the physician. Breastfeeding. It is not known whether simethicone is excreted in human milk. The excretion of simethicone in human milk has not been studied in animals. The decision whether to continue/discontinue breastfeeding or to continue/discontinue simethicone therapy should be made taking into account the benefit of breastfeeding for the child and of simethicone therapy for the woman.
Product Code:FRCM046826
Price Trend
This product has been on sale since 25/09/2017
In the last 30 days, the product's lowest price
was 12,08 €
Richiedi info sul prodotto
